The physiological mechanism of drug induced lung disease in man;MECANISMES PHYSIOPATHOLOGIQUES DES PNEUMOPATHIES MEDICAMENTEUSES CHEZ L'HOMME

Revue des Maladies Respiratoires

Volumn 13, Issue 2, 1996, Pages 127-132

  Israel Biet D ^b   Cadranel, J ^a,b  

^a Hopital Laennec   (France)

^b NONE

Author keywords

Amiodarone; Bleomycin; Drug induced alveolitis; Iatrogenic lung disease

Indexed keywords

AMIODARONE; BCG VACCINE; BLEOMYCIN; MINOCYCLINE; ANTIARRHYTHMIC AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC ANTIBIOTIC; IMMUNOLOGICAL ADJUVANT;

HUMAN; IATROGENIC DISEASE; LUNG DISEASE; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; RADIATION INJURY; RADIATION PNEUMONIA; REVIEW; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DISEASE MODEL; IMMUNOLOGY; LUNG LAVAGE; PATHOLOGY;

ADJUVANTS, IMMUNOLOGIC; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ANTI-BACTERIAL AGENTS; ANTIBIOTICS, ANTINEOPLASTIC; BCG VACCINE; BLEOMYCIN; BRONCHOALVEOLAR LAVAGE FLUID; DISEASE MODELS, ANIMAL; HUMANS; LUNG DISEASES; MINOCYCLINE;

EID: 0029929838     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. AKOUN G, WHITE J : Treatment-induced respiratory disorders. In: Drug-induced disorders. Eds Elsevier,1989:3:24-46.
2. COOPER J, WHITE D, MATTHAY R : Drug-induced pulmonary disease. Noncytotoxic drugs. Am Rev Respir Dis 1986;133:488-505.
3. ISRAËL-BIET D, LABRUNE S, HUCHON G : Drug-induced lung disease : 1990 review. Eur Respir J 1991;4:465-78.
4. DENHOLM E, PHAN S : The effects of bleomycin on alveolar macrophage growth factor secretion. Am J Pathol 1989;134:355-63.
5. JORDANA M, RICHARD C, IRVING L, GAULDIE J : Spontaneous in vitro release of alveolar macrophage cytokines after the intratracheal instillation of bleomycin in rats. Am Rev Respir Dis 1988;137:1135-40.
6. SUWABE A, TAKAHASHI K, YASUI S, ARAI S, SENDO F : Bleomycin-stimulated hamster alveolar macrophages release interleukin-1. Am J Pathol 1988;132;512-20.
7. SCHEULE R, PERKINS R, HAMILTON R, HOLIAN A : Bleomycin-stimulation of cytokine secretion by the human alveolar macrophage. Am J Physiol 1992;262:L386-L391.
8. PIGUET P, COLLART M, GRAU G, KAPANCI Y, VASSALLI P : Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis. J Exp Med 1989;170:655-63.
9. ELIAS J, ROSSMAN M, ZURIER R, DANIELE R : Human alveolar macrophage inhibition of lung fibroblasts growth. A prostaglandin dependent process. Am Rev Respir Dis 1985;131:94-9.
10. CONLEY N, YARBO J, FERRARI H, ZEIDLER R : Bleomycin increases superoxide anion generation by pig peripheral alveolar macrophages. Mol Pharmacol 1986;30:48-52.
11. HOLIAN A, DANIELE R : Stimulation of oxygen consumption and superoxide anion production in pulmonary macrophages by N-formyl methionyl peptides. FEBS lett 1979;108:47-50.
12. GOLDINER P, CARLON G, CVITKOVIC E, SCHEIZER O, HOWLAND W : Factors influencing postoperative morbidity and mortality in patients treated with bleomycin. Br Med J 1978;1:1664-67.
13. RINALDO J, GOLDSTEIN R, SNIDER G : Modification of oxygen toxicity after lung injury by bleomycin in hamster. Am Rev Respir Dis 1982;126:1030-33.
14. SOGAL R, GOTTLIEB A, BOUTROS A et al.: Effect of oxygen on bleomycin-induced lung damage. Clevel Clin J Med 1987;54:503-9.
15. TRYKA A, SKORNIK W, GODLESKI J, BRAIN J : Potentiation of bleomycin-induced lung injury by exposure to 70% oxygen. Morphological assessment. Am Rev Respir Dis 1982;126:1074-9.
16. CAMUS P, JEANNIN L: Speculation on the mechanism for amiodarone-induced pneumonitis. Radiology 1984;150:279-80.
17. MARCHLINSKI F, GANSLER T, WAXMAN H, JOSEPHSON M : Amiodarone pulmonary toxicity. Ann Intern Med 1982;97:839-45.
18. BRAMBILLA C, CHAVEZ L, PIOT M, RIGAUD D, PARAMELLE B : Pneumopathie à l'amiodarone. Presse Med 1983;12:1236.
19. ISRAËL-BIET D, VENET A, CAUBARRERE et al.: Bronchoalveolar lavage in amiodarone pneumonitis. Cellular abnormalities and their relevance to pathogenesis. Chest 1987;91:214-21.
20. NICOLET-CHATELAIN G, PREVOST MC, ESCAMILLA R, MIGUERES J : Amiodarone-induced pulmonary toxicity. Immunoallergologic tests and bronchoalveolar lavage phospholipid content. Chest 1991;99:363-69.
21. LIL F, COHEN R, DOWNAR E, BUTANY J, EDELSON J, REBUCK A : Amiodarone pulmonary toxicity : functional and ultrastructural evaluation. Thorax 1986;41:100-5, 24 juin1994.
22. COUDERT B. BAILLY F, LOMBARD JN, ANDRE F, CAMUS P : Amiodarone pneumonitis. Bronchoalveolar lavage findings in 15 patients and review of the literature. Chest 1992;102:1005-12.
23. OHAR J, JACKSON F, DETTENMEIER P et al.: Bronchoalveolar lavage cell count and differential are not reliable indicators of amiodarone-induced pneumonitis. Chest 1992;102:999-1004.
24. ISRAËL-BIET D, CADRANEL J, JUVIN K et al.: Sustained and compartmentalized of activation alveolar immune and inflammatory cells in drug-induced pneumonitis. Am Rev Respir Dis 1993;A85.
25. AKOUN G, CADRANEL J, BLANCHETTE G. MILLERON B, MAYAUD C : Bronchoalveolar lavage cell data in amiodarone-associated pneumonitis. Evaluation in 22 patients. Chest 1991;99:1177-82.
26. AKOUN G, CADRANEL J, MILLERON B, FLAMMANG D'ORTHO MP, MAYAUD C :Bronchoalveolar lavage cell data in 19 patients with drug-associated pneumonitis (except amiodarone). Chest 1991;99:98-104.
27. AKOUN G, GAUTHIER-RAHMAN S, LIOTE H, MILLERON B, MAYAUD C : Leukocyte migration inhibition in amiodarone-associated pneumonitis. Chest 1988;94:1050-53.
28. SANDRON D, ISRAËL-BIET D, VENET A, CHRÉTIEN J : Immunoglobulin abnormalities in bronchoalveolar lavage specimens from amiodarone-treated subjects. Chest 1986;89:617-8.
29. FAN K, BELL R, EUDY S, FULLENWIDER J : Amiodarone-associated pulmonary fibrosis. Evidence of an immunologically mediated mechanism. Chest 1987;92:625-30.
30. MANICARDI V, BERNINI G, BOSSINI P et al.: Low-dose amiodarone-induced pneumonitis : evidence of an immunologic pathogenetic mechanism. Am J Med 1989;86:134-5.
31. PICHLER W, SCHINDLER L, STAUBLI M, STADLER B, DE WECK A : Antiamiodarone antibodies : detection and relationship to development of side-effects. Am J Med 1988;85:197-202.
32. RABINOWE S, LARSEN P, ANTMAN E et al. : Amiodarone therapy and autoimmune thyroid disease. Increase in a new monoclonal antibody-defined T cell subset. Am J Med 1986;81:54-7.
33. WILSON B, LIPPMANN M : Amiodarone pulmonary toxicity in the rat is associated with increased lavage immunoglobulin and alveolar macrophages primed for increased interleukin-1 secretion. Am J Respir Cell Mol Biol 1993;9:295-9.
34. REASOR M, OGLE C, WALKER E, KACEW : Amiodarone-induced phospholipidosis in rat alveolar macrophages. Am Rev Respir Dis 1988;137:510-8.
35. WILSON B, LIPPMAN M : Pulmonary accumulation of amiodarone and N-Desethylamiodarone. Relationship to the development of pulmonary toxicity. Am Rev Respir Dis 1990;141:1553-8.
36. WILSON B, CLARKSON C, LIPPMANN M : Amiodarone-induced pulmonary inflammation. Correlation with drug dose and lung levels of drug, metabolite and phospholipid. Am Rev Respir Dis 1991;143:1110-4.
37. KARPEL J, MITSUDO S, NORIN A : Natural Killer cell activity in a rat model of amiodarone-induced interstitial lung disease. Chest 1991;99:230-4.
38. WILSON B, CLARKSON C, LIPPMANN M : Amiodarone causes decreased cell-mediated immune responses and inhibits the phospholipase C signaling pathway. Lung 1993;170:137-48.
39. PFITZENMEYER P, FOUCHER P, PIARD F et al.: Nilutamide pneumonitis : a report on eight patients. Thorax 1992;47:622-7.
40. KURASHIMA K, NAKAO S, FUJIMURA M, MATSUDA T : Bucillamine-induced hypersensitivity pneumonitis. Chest 1992;101:1479-80.
41. GUILLON JM, JOLY P, AUTRAN B et al.: Minocycline-induced cell-mediated hypersensitivity pneumonitis. Ann Intern Med 1992;117:476-81.
42. WHITE D, RANKIN J, STOVER D, GELLENE R, GUSTA S : Methotrexate pneumonitis. Bronchoalveolar lavage findings suggest an immunologic disorder. Am Rev Respir Dis 1989;139:18-21.
43. ISRAËL-BIET D, VENET A, SANDRON D, ZIZA JM, CHRÉTIEN J : Pulmonary complications of intravesical bacille Calmette-Guérin immunotherapy. Am Rev Respir Dis 1987;135:763-5.
44. GROSS N : Pulmonary effects of radiation therapy. Ann Intern Med 1971;86:81-92.
45. ROBERTS C, FOULCHER E, ZAUNDERS J et al.: Radiation pneumonitis : a possible lymphocyte-mediated hypersensitivity reaction. Ann Intern Med 1993;118:696-700.
46. CORDIER JF, MORNEX JF, LASNE Y et al.: Bronchoalveolar lavage in radiation pneumonitis. Bull Eur Physiopathol Respir 1984;20:369-74.
47. LAFITTE JJ, GUISELIN M, GOSSELIN B, AERTS C, TONNEL AB, VOISIN C : Diagnostic and predictive value of bronchoalveolar lavage in lung injury after radiotherapy. Am Rev Respir Dis 1986;133:A287.
48. GIBSON P. BRYANT D, ROBINSON B, MCLENNAN G, BREIT S : The role of bronchoalveolar lavage in the assessment of diffuse lung diseases. Aust NZ J Med 1989;19:281-91.